In the 1992–1998 period, orthopaedic biomaterials research foregrounded surfaces engineered to actively interact with biology rather than serve as inert supports. Emphasis fell on bioactive titanium interfaces, surface topography and chemistry to modulate osteoblast activity, and the way micromotion under different loading regimes influences osseointegration and initial implant stability. Researchers also linked surface properties to osteoinductive potential of calcium phosphate materials and recognized wear debris as a key driver of osteolysis, guiding early design decisions for coatings and polymer components.